University of Hertfordshire, Hatfield.
Hertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, Hertfordshire.
Int Clin Psychopharmacol. 2020 Jul;35(4):173-193. doi: 10.1097/YIC.0000000000000314.
In this position statement, developed by The International College of Obsessive-Compulsive Spectrum Disorders, a group of international experts responds to recent developments in the evidence-based management of obsessive-compulsive disorder (OCD). The article presents those selected therapeutic advances judged to be of utmost relevance to the treatment of OCD, based on new and emerging evidence from clinical and translational science. Areas covered include refinement in the methods of clinical assessment, the importance of early intervention based on new staging models and the need to provide sustained well-being involving effective relapse prevention. The relative benefits of psychological, pharmacological and somatic treatments are reviewed and novel treatment strategies for difficult to treat OCD, including neurostimulation, as well as new areas for research such as problematic internet use, novel digital interventions, immunological therapies, pharmacogenetics and novel forms of psychotherapy are discussed.
在这份立场声明中,国际强迫症谱系障碍学院的一组国际专家针对强迫症(OCD)循证管理的最新进展做出了回应。本文根据临床和转化科学的新出现证据,介绍了那些被认为对 OCD 治疗最相关的选定治疗进展。涵盖的领域包括临床评估方法的精细化、基于新分期模型的早期干预的重要性以及提供涉及有效复发预防的持续幸福感的必要性。还审查了心理、药物和躯体治疗的相对益处,并讨论了针对难治性 OCD 的新治疗策略,包括神经刺激,以及研究的新领域,如问题性互联网使用、新型数字干预、免疫疗法、药物遗传学和新型心理治疗形式。